Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson’s Disease

Figure 1

Subject disposition. Among the 55 patients who failed screening, 45 did not meet inclusion/exclusion criteria, 1 was lost to follow-up, 6 withdrew consent (for reasons not involving adverse events), and 3 had other reasons. For reasons other than adverse events. The FAS includes all patients from the treated set who had a baseline and at least 1 postbaseline comprehensive ophthalmology assessment (COA). AE: adverse event and FA: full analysis set.